Experimental Therapy for Rare ALS Tested
Mayo Clinic researchers reported early findings from an experimental treatment designed for a single patient with a rare genetic form of amyotrophic lateral sclerosis (ALS).
Mayo Clinic researchers reported early findings from an experimental treatment designed for a single patient with a rare genetic form of amyotrophic lateral sclerosis (ALS).
Mayo Clinic researchers reported early findings from an experimental treatment designed for a single patient with a rare genetic form of amyotrophic lateral sclerosis (ALS).
Read MoreStudy shows immune responses to flu and COVID-19 trigger lasting inflammation in the spine, hastening onset/progression of amyotrophic lateral sclerosis (ALS).
Read MoreEngineers have combined light and sound imaging methods to observe how blood vessels supply oxygen to active brain neurons in awake animal models.
Read MoreVeterans exposed to high-level explosive blasts face higher rates of emphysema, chronic bronchitis, and stroke years after service.
Read MoreA newly identified group of brain cells actively promotes sleep and coordinates brain rhythms, challenging long-held theories on sleep regulation.
Read MoreProviding mental health coaching and optimizing high-risk medications before surgery reduces post-operative anxiety and depression in older surgical patients.
Read MorePatients with severe asthma show structural brain changes and altered neural communication pathways linked to chronic inflammation.
Read MoreResearchers are examining alternative sleep apnea therapies in children with Down Syndrome, standard surgeries and positive airway pressure devices often fail to resolve breathing issues in this pediatric population.
Read MoreNicotine exposure, including from e-cigarettes and pouches, may heighten the risk of anxiety and depression in teens, particularly in girls.
Read MoreResults from the HOPE-3 trial found that an investigational cell therapy called deramiocel preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy (DMD).
Read MorePatients with long COVID receiving individualized cognitive rehab showed significantly higher goal attainment scores at three months compared to standard care.
Read MoreMonitoring sleep quality could help healthcare providers identify respiratory issues in ALS patients before they become advanced.
Read MoreResearchers found that sialidase inhibitors—a class of flu drugs including oseltamivir (Tamiflu)—protected against degradation of protective sugar molecules tied to cognitive decline and premature aging in people living with HIV.
Read MoreSmoking cessation improves long-term brain health, provided individuals maintain a stable weight following the transition.
Read MorePoor sleep is associated with increased tau protein accumulation and memory issues specifically in women with a higher genetic predisposition to Alzheimer’s disease.
Read MoreImplementing specific protocols for older surgical patients can reduce complications such as delirium, falls, and pneumonia.
Read MoreDegeneration in the locus coeruleus, alongside the hypothalamus, contributes to sleepiness and muscle weakness in narcolepsy type 1.
Read MoreNew research suggests environmental air quality including air pollution plays a significant role in triggering migraine episodes.
Read MoreA clinical trial found that fluvoxamine significantly improved fatigue and quality of life for Long COVID patients with persistent symptoms.
Read MoreCurrently smoking is associated with a lower risk of developing Parkinson’s disease, but quitting smoking was associated with a lower risk of death.
Read MoreNewborns who receive surgery for a severe form of spina bifida are more likely to suffer from breathing disruptions during sleep than previously known.
Read MorePatients with neurocognitive difficulties post COVID-19 infection displayed a significant increase in their blood plasma of a crucial protein linked to neurodegenerative diseases and found in many Alzheimer’s patients.
Read MoreHHS secretary Robert F. Kennedy Jr approved the addition of duchenne muscular dystrophy and metachromatic leukodystrophy to the Recommended Uniform Screening Panel (RUSP).
Read MoreComorbid insomnia and sleep apnea (COMISA) was significantly associated with worse verbal memory outcomes in women, but not in men.
Read More